186 related articles for article (PubMed ID: 33817760)
1. Sentinel Node Biopsy Should Not be Routine in Older Patients with ER-Positive HER2-Negative Breast Cancer Who Are Willing and Able to Take Hormone Therapy.
McKevitt E; Cheifetz R; DeVries K; Laws A; Warburton R; Gondara L; Lohrisch C; Nichol A
Ann Surg Oncol; 2021 Oct; 28(11):5950-5957. PubMed ID: 33817760
[TBL] [Abstract][Full Text] [Related]
2. Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor-Positive Breast Cancer.
Carleton N; Zou J; Fang Y; Koscumb SE; Shah OS; Chen F; Beriwal S; Diego EJ; Brufsky AM; Oesterreich S; Shapiro SD; Ferris R; Emens LA; Tseng G; Marroquin OC; Lee AV; McAuliffe PF
JAMA Netw Open; 2021 Apr; 4(4):e216322. PubMed ID: 33856473
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the Necessity for Routine Sentinel Lymph Node Biopsy in Postmenopausal Patients Being Treated for Clinically Node Negative Breast Cancer the Era of RxPONDER.
Davey MG; Kerin EP; McLaughlin RP; Barry MK; Malone CM; Elwahab SA; Lowery AJ; Kerin MJ
Clin Breast Cancer; 2023 Jul; 23(5):500-507. PubMed ID: 37076364
[TBL] [Abstract][Full Text] [Related]
4. Use of sentinel lymph node biopsy in elderly patients with breast cancer - 10-year experience from a Swiss university hospital.
Heidinger M; Maggi N; Dutilh G; Mueller M; Eller RS; Loesch JM; Schwab FD; Kurzeder C; Weber WP
World J Surg Oncol; 2023 Jun; 21(1):176. PubMed ID: 37287038
[TBL] [Abstract][Full Text] [Related]
5. Luminal A Versus B After Choosing Wisely: Does Lymph Node Surgery Affect Oncologic Outcomes?
Ong C; Blue CM; Khan J; Deng X; Bandyopadhyay D; Louie RJ; McGuire KP
Ann Surg Oncol; 2024 Jan; 31(1):335-343. PubMed ID: 37831277
[TBL] [Abstract][Full Text] [Related]
6. Is it Wise to Omit Sentinel Node Biopsy in Elderly Patients with Breast Cancer?
Sun J; Mathias BJ; Sun W; Fulp WJ; Zhou JM; Laronga C; Loftus LS; Lee MC
Ann Surg Oncol; 2021 Jan; 28(1):320-329. PubMed ID: 32613363
[TBL] [Abstract][Full Text] [Related]
7. Impact of Choosing Wisely Recommendations on Sentinel Lymph Node Biopsy and Postoperative Radiation Rates in Women Over Age 70 Years with Hormone-Positive Breast Cancer.
Thompson J; Le J; Hop A; Melnik M; Paulson J; Wright GP
Ann Surg Oncol; 2021 Oct; 28(10):5716-5722. PubMed ID: 34333704
[TBL] [Abstract][Full Text] [Related]
8. The Extent of Axillary Surgery Is Associated With Breast Cancer-specific Survival in T1-2 Breast Cancer Patients With 1 or 2 Positive Lymph Nodes: A SEER-Population Study.
Li S; Liu F; Chen K; Rao N; Xie Y; Su F; Zhu L
Medicine (Baltimore); 2016 Apr; 95(14):e3254. PubMed ID: 27057872
[TBL] [Abstract][Full Text] [Related]
9. Regional Recurrence Risk Following a Negative Sentinel Node Procedure Does Not Approximate the False-Negative Rate of the Sentinel Node Procedure in Breast Cancer Patients Not Receiving Radiotherapy or Systemic Treatment.
Roos MM; van Steenhoven JEC; Aalders KC; Schreuder K; Burgmans JPJ; Siesling S; Elias S; van Dalen T
Ann Surg Oncol; 2019 Feb; 26(2):372-378. PubMed ID: 30387028
[TBL] [Abstract][Full Text] [Related]
10. Sentinel node biopsy alone for breast cancer patients with residual nodal disease after neoadjuvant chemotherapy.
Chun JW; Kim J; Chung IY; Ko BS; Kim HJ; Lee JW; Son BH; Ahn SH; Lee SB
Sci Rep; 2021 Apr; 11(1):9056. PubMed ID: 33907236
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with node-positive breast cancer: guiding a more selective axillary approach.
Damin AP; Zancan M; Melo MP; Biazus JV
Breast Cancer Res Treat; 2021 Apr; 186(2):527-534. PubMed ID: 33165710
[TBL] [Abstract][Full Text] [Related]
12. Nodal staging affects adjuvant treatment choices in elderly patients with clinically node-negative, estrogen receptor-positive breast cancer.
Laws A; Cheifetz R; Warburton R; McGahan CE; Pao JS; Kuusk U; Dingee C; Quan ML; McKevitt E
Curr Oncol; 2020 Oct; 27(5):250-256. PubMed ID: 33173376
[TBL] [Abstract][Full Text] [Related]
13. How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study.
Mamtani A; Barrio AV; King TA; Van Zee KJ; Plitas G; Pilewskie M; El-Tamer M; Gemignani ML; Heerdt AS; Sclafani LM; Sacchini V; Cody HS; Patil S; Morrow M
Ann Surg Oncol; 2016 Oct; 23(11):3467-3474. PubMed ID: 27160528
[TBL] [Abstract][Full Text] [Related]
14. Sentinel Lymph Node Biopsy Versus Axillary Dissection in Node-Negative Early-Stage Breast Cancer: 15-Year Follow-Up Update of a Randomized Clinical Trial.
Canavese G; Bruzzi P; Catturich A; Tomei D; Carli F; Garrone E; Spinaci S; Lacopo F; Tinterri C; Dozin B
Ann Surg Oncol; 2016 Aug; 23(8):2494-500. PubMed ID: 26975739
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy and timing of sentinel lymph node biopsy in different molecular subtypes of breast cancer with clinically negative axilla.
Bi Z; Liu J; Chen P; Liu Y; Zhao T; Wang C; Zhang Z; Sun X; Qiu P; Cong B; Song X; Wang Y
Breast Cancer; 2019 May; 26(3):373-377. PubMed ID: 30666563
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis.
Park S; Park JM; Cho JH; Park HS; Kim SI; Park BW
Ann Surg Oncol; 2013 Sep; 20(9):2858-65. PubMed ID: 23645483
[TBL] [Abstract][Full Text] [Related]
17. Predicting Survival Benefit of Sparing Sentinel Lymph Node Biopsy in Low-Risk Elderly Patients With Early Breast Cancer: A Population-Based Analysis.
Xu L; Wen N; Qiu J; He T; Tan Q; Yang J; Du Z; Lv Q
Front Oncol; 2020; 10():1718. PubMed ID: 33042815
[No Abstract] [Full Text] [Related]
18. Late Axillary Recurrence After Negative Sentinel Lymph Node Biopsy is Uncommon.
Matsen C; Villegas K; Eaton A; Stempel M; Manning A; Cody HS; Morrow M; Heerdt A
Ann Surg Oncol; 2016 Aug; 23(8):2456-61. PubMed ID: 26957506
[TBL] [Abstract][Full Text] [Related]
19. Effect of axillary lymph node dissection after sentinel lymph node biopsy on overall survival in patients with T1 or T2 node-positive breast cancer: report from the Korean Breast Cancer Society.
Park HS; Chae BJ; Song BJ; Jung SS; Han W; Nam SJ; Youn HJ; Ko BK; Kim DW;
Ann Surg Oncol; 2014 Apr; 21(4):1231-6. PubMed ID: 24318094
[TBL] [Abstract][Full Text] [Related]
20. Oncologic Safety of Sentinel Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy for Breast Cancer.
Wong SM; Basik M; Florianova L; Margolese R; Dumitra S; Muanza T; Carbonneau A; Ferrario C; Boileau JF
Ann Surg Oncol; 2021 May; 28(5):2621-2629. PubMed ID: 33095362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]